Sotera Wireless has been granted FDA approval for the ViSi Mobile continuous, non-invasive blood pressure (cNIBP) monitoring. The system will allow clinicians not to insert a catheter or to have a cuff to continuously monitor systolic and diastolic, beat-to-beat blood pressure along with other core vital signs including pulse rate, skin temperature, electrocardiogram, blood oxygenation and respiration rates. One sensor around the thumb and another placed on the chest are connected to the ViSi Mobile worn on the wrist, and feed all the vitals to the device (ViSi is short for Vital Signals). The data can then be transmitted wirelessly to both desktop and mobile devices for proper tracking, and will alert the physician if vitals indicate patient deterioration. It gives physicians the ability to continuously monitor patient’s vitals 24/7 with the added benefit of not disturbing patients at rest, and the flexibility of allowing patients to venture away from their bedside.

The device performed well in head-to-head comparisons with invasive monitoring systems, measuring blood pressure to within 5mmHg. Sotera plans to expand the ViSi Mobile System to allow monitoring even after the patient has been discharged from the hospital to help clinicians ensure the patient continues to recover and minimize readmission.

source:Sotera Wireless